CuI /反-4-羟基-1-脯氨酸催化的芳基碘化物与叔丁基β-酮酯的偶联在DMF中在40°C下顺利进行,在酸促进叔丁酯的脱保护和脱羧反应后得到α-芳基酮团体。CuI / 2-吡啶甲酸在二恶烷中于70°C催化芳基碘化物与乙酰乙酸叔丁酯偶合时,在自发脱酰作用下释放出α-芳酸叔丁酯。各种各样的官能团,例如乙酰基,甲氧基,腈,硝基,溴和氯与反应条件相容。
Described are RORγ modulators of the formula (I), [INSERT CHEMICAL STRUCTURE HERE] or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORγ activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORγ activity, for example, autoimmune and/or inflammatory disorders.